Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Search by expertise, name or affiliation
Brentuximab vedotin for frontline Hodgkin lymphoma: How much will a successful trial cost patients and payers?
Satish Shanbhag, Vinay Prasad
Knight Cancer Institute
Contribution to journal
Dive into the research topics of 'Brentuximab vedotin for frontline Hodgkin lymphoma: How much will a successful trial cost patients and payers?'. Together they form a unique fingerprint.